Tuesday, January 16, 2018 -- A new study challenges common misconceptions associated with cases of non-ventilator hospital-acquired pneumonia, emphasizing the need for a broader use of preventive measures.
Thursday, January 11, 2018 -- Pneumonia acquired in hospitals is more widespread than previously thought, according to a new study. While hospital-acquired pneumonia has long been associated with the elderly and intensive care units (ICU), the study found that non-ventilator hospital-acquired pneumonia (NV-HAP) occurs across … Read More » The post Study looks at prevalence of hospital-acquired pneumonia appeared first on Life Science Daily.
Tuesday, January 09, 2018 -- A recent study suggests that the new antibiotic combination ceftazidime-avibactam may be a useful alternative for treating hospital-acquired pneumonia.
Wednesday, December 27, 2017 -- Pfizer’s pneumonia vaccine patent has come under legal challenge in India.
Tuesday, December 19, 2017 -- In patients with rheumatic diseases, the incidence of pneumocystis pneumonia was reduced with primary prophylaxis with trimethoprim/sulfamethoxazole.
Monday, December 18, 2017 -- Chris Dall | News Reporter | CIDRAP NewsDec 18, 2017A phase 3 trial shows ceftazidime-avibactam "non-inferior" to meropenem.
Friday, December 15, 2017 -- Ceftazidime-avibactam was non-inferior to meropenem in the treatment of nosocomial pneumonia. These results support a role for ceftazidime-avibactam as a potential alternative to carbapenems in patients with nosocomial pneumonia (including ventilator-associated pneumonia) caused by Gram-negative pathogens.
Friday, December 08, 2017 -- by Fouzia Nahid, Rabaab Zahra, Linus Sandegren Carbapenem resistant Klebsiella pneumoniae (CR-KP) infections are an ever-increasing global issue, especially in the Indian subcontinent. Here we report genetic insight into a blaOXA-181 harbouring Klebsiella pneumoniae, belonging to the pandemic lineage ST147, that represents an intermediate stage towards pan-drug resistance. The CR-KP isolate DA48896 was isolated from a patient from Pakistan and was susceptible only to tigecycline and colistin. It harboured blaOXA-181 and was assigned to sequence type ST147. Analysis from whole genome sequencing revealed a very high sequence similarity to the previously sequenced pan-resistant K. pneumoniae isolate MS6671 from the United Arab Emirates. The two isolates are very closely related with only 46 chromosomal nucleotide differences, 14 indels and differences
Wednesday, December 06, 2017 -- Researchers from Harvard Medical School conducted one of the largest studies to date to examine the impact of pneumococcal vaccines and antibiotic usage on trends in colonization in young, healthy children.
Wednesday, November 29, 2017 -- A blood oxygen level test in addition to 3 other noninvasive tests may be key to helping general practitioners diagnose pneumonia and avoiding unnecessary antibiotic prescriptions.
Monday, November 27, 2017 -- Chris Dall | News Reporter | CIDRAP NewsNov 27, 2017Fever, crackling in the lungs, high pulse, and low blood oxygen may be predictive.
Friday, November 24, 2017 -- NKTR-061 failed to provide additional benefit over standard antibiotic treatment
Wednesday, November 22, 2017 -- Development of effective strategies to limit the proliferation of multidrug-resistant organisms requires a thorough understanding of how such organisms spread among health care facilities. We sought to uncover the chains of transmission underlying a 2008 U.S. regional outbreak of carbapenem-resistant Klebsiella pneumoniae by performing an integrated analysis of genomic and interfacility patient-transfer data. Genomic analysis yielded a high-resolution transmission network that assigned directionality to regional transmission events and discriminated between intra- and interfacility transmission when epidemiologic data were ambiguous or misleading. Examining the genomic transmission network in the context of interfacility patient transfers (patient-sharing networks) supported the role of patient transfers in driving the outbreak, with genomic analysis revealing that a small subset of patient-transfer events was sufficient to
Tuesday, November 21, 2017 -- Patients with chronic obstructive pulmonary disease have an increased risk of developing diabetes or post-diabetes pneumonia, as well as an increased risk for higher mortality compared with individuals without COPD.
Tuesday, November 21, 2017 -- A group of Stanford researchers built an algorithm that outperforms radiologists when it comes to diagnosing pneumonia, adding another layer to the ongoing discussion about how image-based specialties will co-exist with increasingly powerful technology.
Friday, November 17, 2017 -- It took Stanford AI researchers just a month to beat radiologists at the pneumonia game
Tuesday, November 14, 2017 -- by Jieyun Xu, Jing Hu, Pei Yu, Weiwang Wang, Xingxue Hu, Jinsong Hou, Silian Fang, Xiqiang Liu Objective Postoperative pneumonia (POP) is common and results in prolonged hospital stays, higher costs, increased morbidity and mortality. However, data on the incidence and risk factors of POP after oral and maxillofacial surgery are rare. This study aims to identify perioperative risk factors for POP after major oral cancer (OC) surgery. Methods Perioperative data and patient records of 331 consecutive subjects were analyzed in the period of April 2014 to March 2016. We individually traced each OC patient for a period to discharge from the hospital or 45 days after surgery, whichever occur later. Results The incidence of POP after major OC
Monday, November 06, 2017 -- Chris Dall | News Reporter | CIDRAP NewsNov 06, 2017More than two thirds of adult hospital patients are on the drugs longer than needed.
Friday, November 03, 2017 -- Lisa Schnirring | News Editor | CIDRAP NewsNov 03, 2017Using just 1 drug instead of 2 could go a long way in curbing azithromycin use.
Thursday, November 02, 2017 -- A combination of two antibiotics is often prescribed to treat community-acquired pneumonia in children but a JAMA Pediatrics study is now showing that using just one of the two has the same benefit to patients in most cases.